Pancreatic Cancer clinical trials
Showing 201–250 of 265 active trials. Describe your situation to see which ones you may be eligible for.
- Genetic Testing Decision Aid
- Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer
- Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
- Promoting CT Engagement for Pancreatic Cancer With App
- Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
- Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
- Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
- Increasing Germline Genetic Testing for Patients With Cancer
- Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
- Distance-Based Exercise to Preserve Function and Prevent Disability
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- BOLSTER: Learning New Skills to Thrive
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Resilience and Equity in Aging, Cancer, and Health (REACH)
- Video Education With Result Dependent dIsclosure
- Access to Genetic Testing in Underserved Patients With Cancer
- Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
- Addressing Genomic Disparities in Cancer Survivors
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Better Options for Chronic Cancer Pain
- Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
- MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
- Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
- Feasibility Study for Repurposing RET Inhibitors
- A Study of CS231295 in Patients With Advanced Solid Tumors
- Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
- [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
- Wet Heparinized Suction for Abdominal Cancer
- Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer
- EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer
- Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
- e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
- SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent
- Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening
- INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
- Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
- Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer
- A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
- Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
- Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
- Clinical Trial to Treat Stage IV Cancer Patients
- Social Needs App for Oncology Patients Phase II
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.